Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Maria Gabriella Siragusa"'
Publikováno v:
Current Pharmaceutical Design. 18:5405-5410
The aim of this study was to investigate the potential for systemic administration of Methimazole (MMI) through the buccal mucosa as an alternative route for drug delivery. Considering that the most important restriction in buccal drug delivery could
Autor:
Maria Gabriella Siragusa, Vito Marcianò, Domenico Compilato, Fabio Bucchieri, Giulia Giandalia, Antonella Marino Gammazza, Viviana De Caro, Libero Italo Giannola, Giovanni Zummo, Alessandro Pitruzzella, Donna E. Davies, Alberto Fucarino, Carlo Paderni, Stephen T. Holgate, Felicia Farina, Giuseppina Campisi
Publikováno v:
Current Pharmaceutical Design. 18:5411-5420
Since the activity of several conventional anticancer drugs is restricted by resistance mechanisms and dose-limiting side-effects, the design of formulations for local application on malignant lesions seems to be an efficient and promising drug deliv
Autor:
Maria Gabriella Siragusa, Flavia Maria Sutera, Libero Italo Giannola, V. De Caro, Giulia Giandalia
Publikováno v:
International Journal of Pharmaceutics. 429:78-83
The aptitude of ropinirole to permeate the buccal tissue was tested using porcine mucosa mounted on Franz-type diffusion cells as ex vivo model. Drug permeation was also evaluated in presence of various penetration enhancers and in iontophoretic cond
Autor:
Ada Maria Florena, Libero Italo Giannola, Giuseppina Campisi, Giulia Giandalia, Carlo Paderni, Maria Gabriella Siragusa, Viviana De Caro
Publikováno v:
Scopus-Elsevier
5-Fluorouracil (5-FU) is currently used for treatment of oral squamous cell carcinoma (OSCC). 5-FU is given by i.v. although the systemic administration is associated with severe toxic effects and no topical formulations of 5-FU for buccal drug deliv
Autor:
Viviana De Caro, Giuseppina Campisi, Giulia Giandalia, Maria Gabriella Siragusa, Ada Maria Florena, Claudio Tripodo, Libero Italo Giannola
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 67:425-433
Transbuccal drug delivery has got several well-known advantages especially with respect to peroral way. Since a major limitation in buccal drug delivery could be the low permeability of the epithelium, the aptitude of NLX to penetrate the mucosal bar
Autor:
Pierangelo Sardo, Viviana De Caro, Giuseppe Ferraro, Liliana Lamartina, Valerio Rizzo, Maria Gabriella Siragusa, Fabio Carletti, Simonetta Friscia, Giulia Giandalia, Libero Italo Giannola
Publikováno v:
Medicinal chemistry (Shariqah (United Arab Emirates)). 7(1)
A new aminoacidic derivative of valproic acid (VPA) has been synthesized and characterized by analytical and spectral data. The rationale for the preparation of such potential antiepileptic agent is based on the observation that chemical combination
Autor:
Giulia Giandalia, Liliana Lamartina, V. De Caro, Libero Italo Giannola, Maria Gabriella Siragusa
Publikováno v:
ChemInform. 40
Dopamine delivery to the central nervous system (CNS) undergoes the permeability limitations of blood-brain barrier (BBB) which is a selective interface that excludes most water-soluble molecules from entering the brain. Neutral amino acids permeate
Autor:
Ada Maria Florena, Claudio Tripodo, Libero Italo Giannola, Giuseppina Campisi, Lorenzo Lo Muzio, R. Saccone, Maria Gabriella Siragusa, Carlo Paderni
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Transbuccal drug delivery is an attractive way of administration since several well-known advantages are provided, especially with respect to peroral management. Carbamazepine (CBZ) is an anticonvulsant which is useful in controlling neuropathic pain
The most important feature in transbuccal drug delivery is the low drug passage through the buccal mucosa. In our previous work we demonstrated the aptitude of Galantamine to penetrate the buccal tissue. The collected data suggested that Galantamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fcf7103305340842ac6562c354883ea
http://hdl.handle.net/10447/42793
http://hdl.handle.net/10447/42793
Autor:
Viviana De Caro, Maria Gabriella Siragusa, Giulia Giandalia, Lorenzo Cordone, Libero Italo Giannola
Publikováno v:
Journal of ocular pharmacology and therapeutics 24 (2008): 186–196.
info:cnr-pdr/source/autori:Giannola, LI; De Caro, V; Giandalia, G; Siragusa, MG; Cordone, L/titolo:Ocular gelling microspheres: In vitro precorneal retention time and drug permeation through reconstituted corneal epithelium/doi:/rivista:Journal of ocular pharmacology and therapeutics/anno:2008/pagina_da:186/pagina_a:196/intervallo_pagine:186–196/volume:24
info:cnr-pdr/source/autori:Giannola, LI; De Caro, V; Giandalia, G; Siragusa, MG; Cordone, L/titolo:Ocular gelling microspheres: In vitro precorneal retention time and drug permeation through reconstituted corneal epithelium/doi:/rivista:Journal of ocular pharmacology and therapeutics/anno:2008/pagina_da:186/pagina_a:196/intervallo_pagine:186–196/volume:24
Purpose: The model drug norfloxacin (NOR)was encapsulated into trehalose (TRH) and hydroxyethylcellulose(NAT) microspheres to obtain a novel gelling ophthalmic delivery system for prolonged release on corneal tissue. Methods: We assessed NOR release